TR200103278T2 - Spiroimidazolidin türevleri, hazırlanışları, kullanışları ve bunları içeren farmasötik preparatlar. - Google Patents

Spiroimidazolidin türevleri, hazırlanışları, kullanışları ve bunları içeren farmasötik preparatlar.

Info

Publication number
TR200103278T2
TR200103278T2 TR2001/03278T TR200103278T TR200103278T2 TR 200103278 T2 TR200103278 T2 TR 200103278T2 TR 2001/03278 T TR2001/03278 T TR 2001/03278T TR 200103278 T TR200103278 T TR 200103278T TR 200103278 T2 TR200103278 T2 TR 200103278T2
Authority
TR
Turkey
Prior art keywords
cell
formula
compounds
adhesion
preparation
Prior art date
Application number
TR2001/03278T
Other languages
English (en)
Inventor
Wehner Volkmar
Ulrich Stilz Hans
Schmidt Wolfgang
Seiffge Dirk
Original Assignee
Aventis Pharma Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Deutschland Gmbh filed Critical Aventis Pharma Deutschland Gmbh
Publication of TR200103278T2 publication Critical patent/TR200103278T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Neurosurgery (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Mevcut bulus, E, V, W, X, R1 ve R2 nin istemlerde belirtilen anlamlara sahip oldugu formül I'in spiroimidazolidin türevleri ile ilgilidir. Formül (I)'in bilesikleri, örnegin; romatoid artrit ya da alerjik bozukluklar gibi enflamatuvar hastaliklarin tedavisi ya da profilaksisi için uygun olan, farmasötik açidan aktif olan degerli bilesiklerdir. Formül (I)'in bilesikleri, lökositlerin yapisma ve hücre göçü inhibitörleri ve/veya integrinler grubuna ait olan VLA-4 yapisma reseptörü antagonistleridir. Bunlar genellikle, lökosit yapismasi ve/veya lökosit göçünün istenmeyen sonuçlarinin neden oldugu ya da bunlar ile iliskili hastaliklarin ya da VLA-4 reseptörlerinin etkilesimlerine dayanan hücre-hücre veya hücre-matrisk etkilesimlerinin rol oynadigi durumlarinin tedavisi ve profilaksisi için uygundurlar.
TR2001/03278T 1999-05-17 2000-05-06 Spiroimidazolidin türevleri, hazırlanışları, kullanışları ve bunları içeren farmasötik preparatlar. TR200103278T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19922462A DE19922462A1 (de) 1999-05-17 1999-05-17 Spiro-imidazolidinderivate, ihre Herstellung ihre Verwendung und sie enthaltende pharmazeutische Präparate

Publications (1)

Publication Number Publication Date
TR200103278T2 true TR200103278T2 (tr) 2002-04-22

Family

ID=7908208

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/03278T TR200103278T2 (tr) 1999-05-17 2000-05-06 Spiroimidazolidin türevleri, hazırlanışları, kullanışları ve bunları içeren farmasötik preparatlar.

Country Status (28)

Country Link
US (1) US6399643B1 (tr)
EP (1) EP1183241B1 (tr)
JP (1) JP4686029B2 (tr)
KR (1) KR100658962B1 (tr)
CN (1) CN1221535C (tr)
AR (1) AR023989A1 (tr)
AT (1) ATE250038T1 (tr)
AU (1) AU778814B2 (tr)
BR (1) BR0011296B1 (tr)
CA (1) CA2373433C (tr)
CZ (1) CZ301467B6 (tr)
DE (2) DE19922462A1 (tr)
DK (1) DK1183241T3 (tr)
ES (1) ES2204595T3 (tr)
HK (1) HK1047104B (tr)
HU (1) HU228917B1 (tr)
IL (2) IL146276A0 (tr)
MX (1) MXPA01011611A (tr)
NO (1) NO320687B1 (tr)
NZ (1) NZ515496A (tr)
PL (1) PL201421B1 (tr)
PT (1) PT1183241E (tr)
RU (1) RU2245879C2 (tr)
SI (1) SI1183241T1 (tr)
TR (1) TR200103278T2 (tr)
TW (1) TWI256386B (tr)
WO (1) WO2000069831A1 (tr)
ZA (1) ZA200109370B (tr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10111877A1 (de) * 2001-03-10 2002-09-12 Aventis Pharma Gmbh Neue Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
DE10134366A1 (de) * 2001-07-14 2003-01-23 Aventis Pharma Gmbh Verfahren zur Herstellung der enantiomeren Formen von 2-substituierten 2-(2,5-Dioxoimidazolidin-l-yl)-essigsäure- Derivaten
DE10137595A1 (de) 2001-08-01 2003-02-13 Aventis Pharma Gmbh Neue Imidazolidinderivate, ihre Herstellung und ihre Verwendung
SI3326645T1 (sl) 2010-10-25 2020-09-30 Biogen Ma Inc. Metode za determinacijo razlik v alfa- 4 integrin aktivnosti s korelacijo razlik v SVCAM in/ali SMADCAM nivojih

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4009506A1 (de) 1990-03-24 1991-09-26 Hoechst Ag Hydantoinderivate
DE4126277A1 (de) 1991-08-08 1993-02-11 Cassella Ag Hydantoinderivate
DE69309044T3 (de) 1992-01-13 2004-12-23 Biogen, Inc., Cambridge Behandlung von asthma
ATE151642T1 (de) 1992-02-12 1997-05-15 Biogen Inc Behandlung für entzündungserkrankung des darmes
DE4207254A1 (de) 1992-03-07 1993-09-09 Cassella Ag 4-oxo-2-thioxoimidazolidin-derivate
DE4213634A1 (de) 1992-04-24 1993-10-28 Cassella Ag 2,4-Dioxo-imidazolidin-Derivate
DE4224414A1 (de) 1992-07-24 1994-01-27 Cassella Ag Phenylimidazolidin-derivate, ihre Herstellung und ihre Verwendung
DE4228717A1 (de) 1992-08-28 1994-03-03 Cassella Ag Imidazolidin-Derivate
JPH08505628A (ja) 1993-01-08 1996-06-18 田辺製薬株式会社 ペプチド型細胞接着阻害薬
NZ261259A (en) 1993-01-12 1996-12-20 Biogen Inc Humanised recombinant anti-vla4 antibody and diagnostic compositions and medicaments
DK0682529T4 (da) 1993-02-09 2006-05-15 Biogen Idec Inc Antistof til behandling af insulinkrævende diabetes
DE4308034A1 (de) 1993-03-13 1994-09-15 Cassella Ag Neue Heterocyclen, ihre Herstellung und ihre Verwendung
DE4427979A1 (de) 1993-11-15 1996-02-15 Cassella Ag Substituierte 5-Ring-Heterocyclen, ihre Herstellung und ihre Verwendung
AU693143B2 (en) 1993-12-06 1998-06-25 Cytel Corporation CS-1 peptidomimetics, compositions and methods of using the same
ES2424292T3 (es) 1994-01-25 2013-09-30 Biogen Idec Ma Inc. Anticuerpos humanizados contra la molécula de adhesión leucocitaria VLA-4
EP0767674A4 (en) 1994-06-29 1999-06-16 Texas Biotechnology Corp METHOD FOR INHIBITING THE BINDING OF INTEGRIN ALPHA 4 BETA 1 TO VCAM-1 OR FIBRONECTIN
US5811391A (en) 1994-08-25 1998-09-22 Cytel Corporation Cyclic CS-1 peptidomimetics, compositions and methods of using same
GB9524630D0 (en) 1994-12-24 1996-01-31 Zeneca Ltd Chemical compounds
US6248713B1 (en) 1995-07-11 2001-06-19 Biogen, Inc. Cell adhesion inhibitors
ATE212990T1 (de) 1996-03-20 2002-02-15 Hoechst Ag Inhibitoren der knochenresorption und vitronectinrezeptor-antagonisten
KR20040084945A (ko) 1996-07-25 2004-10-06 바이오겐 아이덱 엠에이 인코포레이티드 세포 유착 억제제
PL323130A1 (en) * 1996-11-15 1998-05-25 Hoechst Ag Application of heterocyclic compounds in production of a pharmaceutic agent, novel heterocyclic compounds and pharmaceutic agent as such
DE19647380A1 (de) * 1996-11-15 1998-05-20 Hoechst Ag 5-Ring-Heterocyclen als Inhibitoren der Leukozytenadhäsion und VLA-4-Antagonisten
DE19647381A1 (de) * 1996-11-15 1998-05-20 Hoechst Ag Neue Heterocyclen als Inhibitoren der Leukozytenadhäsion und VLA-4-Antagonisten
DE19648053C1 (de) 1996-11-20 1998-03-12 Siemens Ag Elektromagnetisches Schaltgerät
WO1998042656A1 (en) 1997-03-21 1998-10-01 Cytel Corporation Novel compounds
DE19741235A1 (de) * 1997-09-18 1999-03-25 Hoechst Marion Roussel De Gmbh Neue Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
DE19741873A1 (de) * 1997-09-23 1999-03-25 Hoechst Marion Roussel De Gmbh Neue 5-Ring-Heterocyclen, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
DE19751251A1 (de) * 1997-11-19 1999-05-20 Hoechst Marion Roussel De Gmbh Substituierte Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmezeutische Präparate
DE19821483A1 (de) * 1998-05-14 1999-11-18 Hoechst Marion Roussel De Gmbh Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate

Also Published As

Publication number Publication date
CN1356986A (zh) 2002-07-03
HK1047104B (zh) 2006-02-03
JP4686029B2 (ja) 2011-05-18
NO20015617D0 (no) 2001-11-16
NO320687B1 (no) 2006-01-16
CA2373433A1 (en) 2000-11-23
WO2000069831A1 (en) 2000-11-23
TWI256386B (en) 2006-06-11
ZA200109370B (en) 2002-06-27
SI1183241T1 (en) 2004-02-29
HUP0202364A3 (en) 2003-10-28
KR100658962B1 (ko) 2006-12-21
DK1183241T3 (da) 2004-01-19
MXPA01011611A (es) 2003-09-10
IL146276A0 (en) 2002-07-25
HUP0202364A2 (hu) 2002-11-28
HU228917B1 (hu) 2013-06-28
AU4756000A (en) 2000-12-05
US6399643B1 (en) 2002-06-04
ES2204595T3 (es) 2004-05-01
AR023989A1 (es) 2002-09-04
NZ515496A (en) 2003-10-31
ATE250038T1 (de) 2003-10-15
CA2373433C (en) 2010-12-14
PL201421B1 (pl) 2009-04-30
DE60005337D1 (de) 2003-10-23
CZ20014089A3 (cs) 2002-02-13
AU778814B2 (en) 2004-12-23
KR20010113957A (ko) 2001-12-28
DE19922462A1 (de) 2000-11-23
JP2002544261A (ja) 2002-12-24
CZ301467B6 (cs) 2010-03-10
EP1183241A1 (en) 2002-03-06
NO20015617L (no) 2002-01-15
BR0011296B1 (pt) 2011-08-23
EP1183241B1 (en) 2003-09-17
CN1221535C (zh) 2005-10-05
PL351755A1 (en) 2003-06-16
PT1183241E (pt) 2004-02-27
BR0011296A (pt) 2002-02-26
DE60005337T2 (de) 2004-06-24
HK1047104A1 (en) 2003-02-07
RU2245879C2 (ru) 2005-02-10
IL146276A (en) 2007-06-03

Similar Documents

Publication Publication Date Title
DE59915127D1 (de) Imidazolidinderivate, ihre herstellung, ihre verwendung und sie enthaltende pharmazeutische präparate
MY118313A (en) Substituted imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
MY123865A (en) Novel heterocycles as inhibitors of leucocyte adhesion and as vla-4 antagonists
MY118176A (en) Heterocycles as inhibitors of leucocyte adhesion and as vla-4-antagonists
BR9705727A (pt) Heterocicilos com anel de cinco membros como inibidores da adesão de leucócitos e como antigonistas de vla-4.
BR9916980A (pt) Derivados bicìclicos substituìdos úteis como agentes anticancerìgenos
MY121745A (en) 2,4-substituted imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them.
DE69713582T2 (de) Zimtsäurederivate und deren verwendung als integrin-antagonisten
BG104138A (en) 2-aminopyridines containing substituents with condensed rings as nos inhibitors
DE60041763D1 (de) Inhibitoren von c-jun n-terminal kinasen (jnk)
DE60038686D1 (de) Oheptan-derivate und ihre verwendung als integrin-rezeptor-antagonisten
MY134191A (en) Novel 5-membered ring heterocycles, their preparation their use and pharmaceutical preparations comprising them
FI973283A (fi) 5-(4-substituoitu piperidinyyli-1)-3-aryyli-valeriaanahappojohdannaisia takykiniinireseptoriantagonisteina
BR9607335A (pt) Compostos 1-aril-2-acrilamino-etano e seu uso como neuroquinina especialmente antogonistas de neuroquinina 1
ATE277010T1 (de) Bis-indolederivate und ihre verwendung als entzündungshemmende mittel
TR200103278T2 (tr) Spiroimidazolidin türevleri, hazırlanışları, kullanışları ve bunları içeren farmasötik preparatlar.
TR200103856T2 (tr) Naftiridin türevleri, bunların preparasyon işlemleri, kullanımları ve farmasötik kompozisyonlar.
NO20033981L (no) Imidazolidinderivater, deres fremstilling og deres anvendelse som antiinflammatorisk middel
HK1066166A1 (en) Novel imidazolidine derivatives, their preparation and their use as vla-4 antagonists
Rosenthal et al. Comparative effects on the immune system of methotrexate and trimetrexate
TR200103858T2 (tr) Hücre yapışmasının önleyicileri olarak ikame edilmiş purin türevleri
TH64558A (tr)